These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26704708)

  • 1. Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model.
    Kim Y; Choi H; Lee W; Park H; Kam TI; Hong SH; Nah J; Jung S; Shin B; Lee H; Choi TY; Choo H; Kim KK; Choi SY; Kayed R; Jung YK
    Neurobiol Dis; 2016 Mar; 87():19-28. PubMed ID: 26704708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimozide reduces toxic forms of tau in TauC3 mice via 5' adenosine monophosphate-activated protein kinase-mediated autophagy.
    Kim YD; Jeong EI; Nah J; Yoo SM; Lee WJ; Kim Y; Moon S; Hong SH; Jung YK
    J Neurochem; 2017 Sep; 142(5):734-746. PubMed ID: 28632947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
    Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abolishing Tau cleavage by caspases at Aspartate
    Biundo F; d'Abramo C; Tambini MD; Zhang H; Del Prete D; Vitale F; Giliberto L; Arancio O; D'Adamio L
    Transl Psychiatry; 2017 Aug; 7(8):e1198. PubMed ID: 28786980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-2 cleavage of tau reversibly impairs memory.
    Zhao X; Kotilinek LA; Smith B; Hlynialuk C; Zahs K; Ramsden M; Cleary J; Ashe KH
    Nat Med; 2016 Nov; 22(11):1268-1276. PubMed ID: 27723722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.
    Xu H; Rösler TW; Carlsson T; de Andrade A; Bruch J; Höllerhage M; Oertel WH; Höglinger GU
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):833-43. PubMed ID: 24865638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
    Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
    J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
    Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F
    Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization.
    Shirafuji N; Hamano T; Yen SH; Kanaan NM; Yoshida H; Hayashi K; Ikawa M; Yamamura O; Kuriyama M; Nakamoto Y
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging.
    Means JC; Gerdes BC; Kaja S; Sumien N; Payne AJ; Stark DA; Borden PK; Price JL; Koulen P
    Neurochem Res; 2016 Sep; 41(9):2278-88. PubMed ID: 27220334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy.
    Chang JK; Leso A; Subaiea GM; Lahouel A; Masoud A; Mushtaq F; Deeb R; Eid A; Dash M; Bihaqi SW; Zawia NH
    Curr Alzheimer Res; 2018; 15(7):655-663. PubMed ID: 29357795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
    Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
    J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits.
    Wang H; Wang R; Carrera I; Xu S; Lakshmana MK
    eNeuro; 2016; 3(2):. PubMed ID: 27257626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.